IGR In-vitro Diagnostics Instruments Market | Page 3

instruments market based on end user is segmented into hospitals and diagnostic laboratories, homecare and academic and research institutes. Make an Enquiry:- https://www.infiniumglobalresearch.com/Reports/MakeEnquiryRequest/807 Geographic Coverage and Analysis: The report provides regional analysis covering geographies such as Americas, Europe, Asia-Pacific and Rest of the World. In this section the key trends and market size for each geography is provided over the period of 2015 – 2023. Americas was the largest market among the geographies due to developed healthcare systems in the U.S. & Canada, and rising acceptance of technologically advanced products in this region. Following the Americas and Europe were also accounted to have a strong hold on global in-vitro diagnostics instruments market. Furthermore, these regions are expected to have a moderate growth rate over the forecast period. Moreover, Asia-Pacific region is expected to grow at a highest CAGR, due to the growth in research activities and increasing investments by leading players in the region. Moreover, Middle East and Africa (covered in ROW region) is expected to grow gradually over the forecast period due to rapid industrialization and changing lifestyle of the consumers in Brazil and other countries. Companies Profiled: The companies covered in the report include Abbott Laboratories, Inc., Siemens AG, Sysmex Corporation, Becton, Dickinson and Company, Ortho-Clinical Diagnostics, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, Thermo Fisher Scientific, Inc., Qiagen N.V., Johnson & Johnson, Roche Diagnostics, Diasorin S.P.A., Biomérieux SA.